Monoclonal antibody treatments becoming more accessible
A hot topic brought to you by SpecialtyRx, your partner in long-term care
The federal government is working to improve access to monoclonal antibody treatments, which are proven effective in controlling the severity of the infection. With better staffing and equipment, LTC facilities will see an increase in their ability to treat their COVID-19 infected patients.
The Department of Health and Human Services’ new initiative, the Long-Term Care Infusion Support Activity, or LISA, coalition has made members of its civilian Medical Reserve Corps available to create infusion programs. They are also available to administer the drugs in 800 communities across the country. HHS has also committed an additional $150 million toward the infusions.
According to Capt. David Wong, chief medical officer of the HHS Office of Minority Health, 5,000 facilities nationwide administered antibody treatments, but only about 35% of 900,000 available treatments have been used. Any LTC facilities interested in the program can contact their local state health departments to get in touch with the Corps.